FDA approves TB pill that cures more hard-to-treat patients
TRENTON, N.J. — U.S. regulators Wednesday approved a new tuberculosis medicine that shortens and improves treatment for the hardest-to-treat cases, a worsening problem in many poor countries.
It’s the first TB drug from a nonprofit group. The TB Alliance, formed to come up with better treatments, developed pretomanid with help from charities and government agencies.
Read Original Article: FDA approves TB pill that cures more hard-to-treat patients »
